Document:

Letter Amendment dated January 8, 2003

 
EXHIBIT
10.10.1 
 
January 8, 2003 
 
 
*** 
*** 
Natus
Medical Inc. 
1501 Industrial Road 
San Carlos, CA 94070-4111 
 
RE:    Extension of Agreement #CE90270 
 
Dear ***: 
 
Natus Medical Inc. and Novation, LLC
agree to extend the above-referenced Agreement through January 31, 2004. In addition Natus and Novation agree to make the following changes to the Supplier Agreement: 
 
1a.    Purchasing and Leasing Opportunities for Members.    In the
5th sentence delete “a Member” for purposes of this Agreement and replace with “eligible Member to
participate in this Agreement”. Also, in the 5th sentence delete the second “a Member” and replace
with “eligible Member.” Definition of “eligible Member” is found in Section 2a below. 
 
2a.    Letter of Award.    Delete the first sentence and replace with the following: “By executing and delivery the Letter of Award attached
hereto as Exhibit D (“Award Letter”) to Supplier, Novation will have accepted the Bid, and Novation and Supplier therefore agree that Supplier will make Products available for purchase and/or lease by the Members that have completed a
Letter of Participation (attached hereto in Exhibit A), at the Award Prices in accordance with the terms of this Agreement and the forms of purchase, lease, financing or servicing agreements, if any, attached hereto in Exhibit E (collectively,
“Forms”); provided, however, that Novation’s award of this Agreement to Supplier will not constitute a commitment by any person to purchase or lease any of the products. All subsequent reference in this Agreement to
“Members” shall refer to those having completed the Letter of Participation.” 
 
9a.    Marketing Fees Calculation.    In the fifth line: after “revenues” change to less *** and ***, and then add “to the participating
Members, directly or indirectly from Supplier (now add) “during the Term of this Agreement” and strike remaining part of this sentence. 
 
Exhibit A.    The current Exhibit A is replaced with the attached Exhibit A effective February 1, 2003. The revised Letter of
Participation reflecting these changes is also attached. 
 
Exhibits B and D.    Delete references to Super Committed Participation Level. 
 
All other terms and conditions of the current Agreement will remain in full force and effect. 
 
Please indicate your acceptance of this extension as amended by signing in the space provided below, and returning one signed
original to *** at your earliest convenience. A copy is provided for your records. 
 
Sincerely, 
 
/s/    Larry Dooley 
 
Larry
Dooley 
Vice President 
Contract
and Program Services 
 

***Confidential treatment requested pursuant to a request for confidential treatment filed with
the Securities and Exchange Commission. Omitted portions have been filed separately with the Commission. 

 
AGREED TO AND ACCEPTED this
30th day of January, 2003. 
 

	 Natus Medical Inc.

	
	 By:
	  	     /s/    KENNETH M.
TRAVERSO

	 Printed Name:
	  	         Kenneth M.
Traverso

	 Title:
	  	 Vice President of Marketing &
Sales            

 

***Confidential treatment requested pursuant to a request for confidential treatment filed with
the Securities and Exchange Commission. Omitted portions have been filed separately with the Commission. 

 
EXHIBIT A

EFFECTIVE 2/1/2003 
 
NATUS MEDICAL 
NOVATION AGREEMENT 
CE90270 
 

	 	  	 	  	 LIST PRICE

	    	 NOVATION PRICING

	    	 
	 Item Description

	  	 UOM

	  	    	 UOM-NOV

	  	 PRICE

	    	 PER SCREEN

	    	 DISCOUNT

	 ALGO 3
	  	 1 Unit
	  	 $
	 18,500.00
	    	 ***
	  	 ***
	    	 	    	 ***

	 ALGO 3
	  	 1 Unit
	  	 $
	 18,500.00
	    	 ***
	  	 ***
	    	 	    	 ***

	 ALGO 3 Trade-In Guarantee
	  	 1 Unit
	  	 	 	    	 	  	 ***
	    	 	    	 
	
	 ALGO 2eC
	  	 1 Unit
	  	 $
	 17,500.00
	    	 ***
	  	 ***
	    	 	    	 ***

	 ALGO 2eC
	  	 1 Unit
	  	 $
	 17,500.00
	    	 ***
	  	 ***
	    	 	    	 ***

	 ALGO 2eC Trade-In Guarantee
	  	 1 Unit
	  	 	 	    	 	  	 ***
	    	 	    	 
	
	 ALGO Portable
	  	 1 Unit
	  	 $
	 10,900.00
	    	 ***
	  	 ***
	    	 	    	 ***

	 ALGO Portable
	  	 1 Unit
	  	 $
	 10,900.00
	    	 	  	 	    	 	    	 
	 ALGO Portable Trade-In Guarantee
	  	 1 Unit
	  	 	 	    	 	  	 ***
	    	 	    	 
	
	 ALGO-Colorado Pak
	  	 	  	 	 	    	 	  	 	    	 	    	 
	 ALGO-Colorado Pak LG
	  	 	  	 	 	    	 Single Order or *** Standing Order

	 ALGO-PAK
	  	 1 Box (of 36 prs)
	  	 $
	 351.00
	    	 ***
	  	 ***
	    	 ***
	    	 ***

	 	  	 1 Box (of 36 prs)
	  	 $
	 351.00
	    	 ***
	  	 ***
	    	 ***
	    	 ***

	 	  	 1 Box (of 36 prs)
	  	 $
	 351.00
	    	 ***
	  	 ***
	    	 ***
	    	 ***

	 	  	 1 Box (of 36 prs)
	  	 $
	 351.00
	    	 ***
	  	 ***
	    	 ***
	    	 ***

	 	  	 1 Box (of 36 prs)
	  	 $
	 351.00
	    	 ***
	  	 ***
	    	 ***

	 	  	 1 Box (of 36 prs)
	  	 $
	 351.00
	    	 	  	 	    	 	    	 
	 	  	 1 Box (of 36 prs)
	  	 $
	 351.00
	    	 	  	 	    	 	    	 
	 	  	 	  	 	 	    	 Single Order or *** Standing Order

	 MINIMUFFS NEO NOISEATTNRS
	  	 1 Unit
	  	 $
	 180.00
	    	 ***
	  	 ***
	    	 ***
	    	 ***

	 MINIMUFFS NEO NOISEATTNRS 36BX
	  	 1 Unit
	  	 $
	 180.00
	    	 	  	 	    	 	    	 
	 MINIMUFFS NEO NOISEATTNRS 36BX
	  	 1 Unit
	  	 $
	 180.00
	    	 	  	 	    	 	    	 
	 MINIMUFFS NEO NOISEATTNRS 36BX
	  	 1 Unit
	  	 $
	 180.00
	    	 	  	 	    	 	    	 
	 MINIMUFFS NEO NOISEATTNRS 36BX
	  	 1 Unit
	  	 $
	 180.00
	    	 	  	 	    	 	    	 
	 MINIMUFFS NEO NOISEATTNRS 36BX
	  	 1 Unit
	  	 $
	 180.00
	    	 	  	 	    	 	    	 
	 	  	 	  	 	 	    	 New Items on Contract

	 JELLY BUTTON SENSORS 150/BOX
	  	 EA
	  	 $
	 120.00
	    	 	  	 ***
	    	 	    	 ***

	 JELLY TAB SENSORS 120/Box
	  	 EA
	  	 $
	 96.00
	    	 	  	 ***
	    	 	    	 ***

	
	 PRINTER LABELS 140 PER ROLL
	  	 EA
	  	 $
	 25.00
	    	 	  	 ***
	    	 	    	 ***

	 THERMAL PRINTER PAPER 8 ROLLS
	  	 EA
	  	 $
	 25.00
	    	 	  	 ***
	    	 	    	 ***

	 REPORT FORM STICKERS 25 PER PK
	  	 EA
	  	 $
	 18.75
	    	 	  	 ***
	    	 	    	 ***

 

***Confidential treatment requested pursuant to a request for confidential treatment filed with
the Securities and Exchange Commission. Omitted portions have been filed separately with the Commission. 

 
NOVATION 
LETTER OF PARTICIPATION 
2/1/03 
Natus Infant Hearing Screening Equipment Contract (CE90270) 
 
Hospital:    __________________________________________
    Address:    ___________________________________ 
 
City, State, Zip:     ________________________________________________    Phone:    __________________________ 
 
Annual Birth
Rate:    ____________________________________________ 
 
Freight—FOB Origin, Prepaid and Added to Invoice 
 
1.     ALGO® SCREENER PRICING: 
 

	 Model
	  	 P/N
	  	 List Price
	    	 Novation Price

	 ALGO®3
	  	 010038
	  	 $18,500
	    	 ***

	 ALGO 2eColor
	  	 010050
	  	 $17,500
	    	 ***

	 ALGO Portable
	  	 010049
	  	 $10,900
	    	 ***

 

	2.	 	Colorado-Pak (P/N 040112 & 040170) and ALGO PAK (P/N 040546) List Price $***  
Single Purchaser—SINGLE ORDER OR 12 MONTH STANDING
ORDER PRICING 

 

	 Screens
	  	 Boxes
	    	 Discount
	  	 Box Price
	  	 Screen Price
	    	 Indicate *** Standing Order

	 ***
	  	 ***
	    	 ***
	  	 ***
	  	 ***
	    	 
	 ***
	  	 ***
	    	 ***
	  	 ***
	  	 ***
	    	 
	 ***
	  	 ***
	    	 ***
	  	 ***
	  	 ***
	    	 
	 ***
	  	 ***
	    	 ***
	  	 ***
	  	 ***
	    	 
	 ***
	  	 ***
	    	 ***
	  	 	  	 	    	 

 

	A.	 	Natus Medical Inc. will apply Novation contract supply pricing to customers with *** on the *** of the month *** of this form at Natus. 

	B.	 	Natus Medical will provide assistance in determining appropriate Standing Order quantities and delivery periods. Standing Order shipments will be audited every ***
to ***. 

 
As a representative of the hospital, I
verify that the hospital wishes to participate in the Natus contract CE90270. 
 
Name    ____________________________________    Signature    _________________________________________________ 
 
Title    _____________________________________    Date    _____________________________________________________ 
 
As a representative of Natus Medical, I verify that *** 
 
Name    ____________________________________    Signature    _________________________________________________ 
 
Title    _____________________________________    Date    _____________________________________________________ 
 
PLEASE RETURN COMPLETED FORM TO: 
 
NATUS MEDICAL INC., Attn: Customer Service, 1501 Industrial Road, San Carlos, CA 94070-4111 
Phone: 800-255-3901    Fax: 650-802-6620 
 

***Confidential treatment requested pursuant to a request for confidential treatment filed with the
Securities and Exchange Commission. Omitted portions have been filed separately with the Commission.Employment Agreement dated as of November 18, 2002

 
EXHIBIT 10.23

 
NATUS MEDICAL, INC. 
 
TIM C. JOHNSON EMPLOYMENT AGREEMENT 
 
This Agreement is entered into as of November 18, 2002, (the
“Effective Date”) by and between Natus Medical, Inc. (the “Company”), and Tim C. Johnson (“Executive”). 
 
1.    Duties and Scope of Employment. 
 
(a)    Positions and Duties.    As of the Effective Date,
Executive will serve as President and Chief Executive Officer of the Company. Executive will render such business and professional services in the performance of his duties, consistent with Executive’s position within the Company, as shall
reasonably be assigned to him by the Company’s Chief Executive Officer (“CEO”). The period of Executive’s employment under this Agreement is referred to herein as the “Employment Term.” 
 
(b)    Obligations.    During the Employment Term, Executive will perform his duties faithfully and to the best of his ability and will devote his full business efforts and time to the
Company. For the duration of the Employment Term, Executive agrees not to actively engage in any other employment, occupation or consulting activity for any direct or indirect remuneration without the prior approval of the Board. 
 
2.    At-Will
Employment.    The parties agree that Executive’s employment with the Company will be “at-will” employment and may be terminated at any time with or without cause or notice. Executive understands and agrees
that neither his job performance nor promotions, commendations, bonuses or the like from the Company give rise to or in any way serve as the basis for modification, amendment, or extension, by implication or otherwise, of his employment with the
Company. 
 
3.    Compensation.

 
(a)    Base
Salary.    During the Employment Term, the Company will pay Executive an annual salary of $280,000.00 as compensation for his services (the “Base Salary”). The Base Salary will be paid periodically in accordance
with the Company’s normal payroll practices and be subject to the usual, required withholding. Executive’s salary will be subject to review and adjustments will be made based upon the Company’s normal performance review practices.

 
4.    Employee
Benefits.    During the Employment Term, Executive will be entitled to participate in the employee benefit plans currently and hereafter maintained by the Company of general applicability to other senior executives of the
Company, including, without limitation, the Company’s group medical, dental, vision, disability, life insurance, and flexible-spending account plans. The Company reserves the right to cancel or change the benefit plans and programs it offers to
its employees at any time. 
 
5.    Paid
Time Off (“PTO”).    Executive is entitled to receive PTO pursuant to Natus’ standard benefit policy currently and hereafter maintained by the Company, and as may be cancelled or changed from time to time.

 
6.    Expenses.    The Company will reimburse Executive for reasonable travel, entertainment or other expenses incurred by Executive in the furtherance of or in connection with the
performance of Executive’s duties hereunder, in accordance with the Company’s expense reimbursement policy as in effect from time to time. 
 
7.    Severance. 
 
(a)    Involuntary Termination.    If Executive’s employment with the Company
terminates other than for “Cause” (as defined herein), death or disability, and Executive signs and does not revoke a standard release of claims with the Company, then, subject to Section 11, Executive shall be entitled to (i) receive
continuing payments of severance pay (less applicable withholding taxes) at a rate equal to his Base Salary rate, as then in effect, for a period eighteen (18) months from the date of such termination, to be paid periodically in accordance with the
Company’s 

 

1 

normal payroll policies; (ii) the immediate vesting and exercisability of 100% of the shares subject to all of Executive’s stock options
to purchase Company Common Stock (whether currently outstanding or granted in following the Effective Date) outstanding on the date of such termination (the “Stock Options”) and (iii) continued payment by the Company of the group health
continuation coverage premiums for Executive and Executive’s eligible dependents under Title X of the Consolidated Budget Reconciliation Act of 1985, as amended (“COBRA”) as in effect through the lesser of (x) eighteen (18) months
from the effective date of such termination, (y) the date upon which Executive and Executive’s eligible dependents become covered under similar plans, or (z) the date Executive no longer constitutes a “Qualified Beneficiary” (as such
term is defined in Section 4980B(g) of the Internal Revenue Code of 1986, as amended (the “Code”)); provided, however, that Executive will be solely responsible for electing such coverage within the required time periods. 
 
(b)    Voluntary Termination;
Termination for Cause.    If Executive’s employment with the Company terminates voluntarily by Executive (other than as described in subsection (c) below) or for Cause by the Company or due to Executive’s death or
disability, then (i) all vesting of Stock Options will immediately cease, (ii) all payments of compensation by the Company to Executive hereunder will terminate immediately (except as to amounts already earned), and (iii) Executive will only be
eligible for severance benefits, if any, in accordance with the Company’s established policies as then in effect. 
 
(c)    Change of Control Benefits.    If within twelve (12) months following a “Change
of Control” (as defined below) (i) Executive terminates Executive’s employment with the Company for Good Reason, or (ii) the Company or the successor corporation terminates Executive’s employment with the Company for other than Cause,
death or disability, then Executive shall be entitled to the benefits provided for in subsection (a). Executive shall only be permitted to receive the benefits provided for in subsection (a) once and shall not be permitted to claim such benefits
under both subsection (a) and (c) such that Executive would receive the benefits pursuant to subsection (a) twice. 
 
8.    Limitation on Payments.    In the event that the severance and other benefits provided for in this
Agreement or otherwise payable to the Executive (i) constitute “parachute payments” within the meaning of Section 280G of the Code and (ii) but for this Section 8, would be subject to the excise tax imposed by Section 4999 of the Code,
then the Executive’s severance benefits under Section 4(a)(i) shall be either: 
 

	 	•	 	delivered in full, or 

 

	 	•	 	delivered as to such lesser extent which would result in no portion of such severance benefits being subject to excise tax under Section 4999 of the Code,

 

	 	•	 	whichever of the foregoing amounts, taking into account the applicable federal, state and local income taxes and the excise tax imposed by Section 4999, results in
the receipt by Executive on an after-tax basis, of the greatest amount of severance benefits, notwithstanding that all or some portion of such severance benefits may be taxable under Section 4999 of the Code. Unless the Company and Executive
otherwise agree in writing, any determination required under this Section 8 shall be made in writing by the Company’s independent public accountants immediately prior to Change of Control (the “Accountants”), whose determination shall
be conclusive and binding upon Executive and the Company for all purposes. For purposes of making the calculations required by this Section 8, the Accountants may make reasonable assumptions and approximations concerning applicable taxes and may
rely on reasonable, good faith interpretations concerning the application of Sections 280G and 4999 of the Code. The Company and Executive shall furnish to the Accountants such information and documents as the Accountants may reasonably request in
order to make a determination under this Section. The Company shall bear all costs the Accountants may reasonably incur in connection with any calculations contemplated by this Section 8. 

 
9.    Definitions. 
 
(a)    Cause.    For purposes of this Agreement, “Cause” shall mean (i) any act of personal dishonesty taken by Executive in connection with his responsibilities as an employee
and intended to result in substantial personal enrichment of Executive, (ii) Executive’s conviction of a felony, (iii) a willful act by Executive which constitutes gross misconduct and which is injurious to the Company, or (iv) continued
substantial violations by Executive of Executive’s employment duties which are demonstrably willful and deliberate on Executive’s part after there has been delivered to Executive a written demand for performance from the Company which
specifically sets forth the factual basis for the Company’s belief that Executive has not substantially performed Executive’s duties. 
 

2 

 
(b)    Change of Control.    For purposes of this Agreement, “Change of Control” of the Company is defined as: 
 
(i)    any “person” (as such term is used in Sections 13(d) and 14(d) of the
Securities Exchange Act of 1934, as amended) is or becomes the “beneficial owner” (as defined in Rule 13d-3 under said Act), directly or indirectly, of securities of the Company representing 50% or more of the total voting power
represented by the Company’s then outstanding voting securities; or 
 
(ii)    a change in the composition of the Board occurring within a two-year period, as a result of which fewer than a majority of the directors are Incumbent Directors. “Incumbent Directors”
will mean directors who either (A) are directors of the Company as of the date hereof, or (B) are elected, or nominated for election, to the Board with the affirmative votes of at least a majority of the Incumbent Directors at the time of such
election or nomination (but will not include an individual whose election or nomination is in connection with an actual or threatened proxy contest relating to the election of directors to the Company); or 
 
(iii)    the date of the consummation of
a merger or consolidation of the Company with any other corporation that has been approved by the stockholders of the Company, other than a merger or consolidation which would result in the voting securities of the Company outstanding immediately
prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity) more than forty percent (40%) of the total voting power represented by the voting securities of the Company
or such surviving entity outstanding immediately after such merger or consolidation, or the stockholders of the Company approve a plan of complete liquidation of the Company; or 
 
(iv)    the date of the consummation of the sale or disposition by the Company of all or
substantially all the Company’s assets; or 
 
(v)    the termination of the CEO (in place on the Effective Date) for other than Cause, death or disability. 
 
(c)    Good Reason.    For purposes of this Agreement, “Good Reason” shall mean
without the Executive’s express written consent shall mean (i) the significant reduction of the Executive’s duties or responsibilities relative to Executive’s duties or responsibilities in effect immediately prior to such reduction;
provided, however, that a reduction in duties or responsibilities solely by virtue of the Company being acquired and made part of a larger entity (as, for example, when the Chief Financial Officer of Natus Medical Incorporated remains as such
following a Change of Control and is not made the Chief Financial Officer of the acquiring corporation) shall not constitute “Good Reason;” (ii) a reduction by the Company in Executive’s annual Base Salary as in effect immediately
prior to such reduction; (iii) a material reduction by the Company in the kind or level of employee benefits to which Executive is entitled immediately prior to such reduction with the result that Executive’s overall benefits package is
significantly reduced; (iv) the relocation of Executive to a facility or a location more than 35 miles from Executive’s then present location, without Executive’s express written consent; or (v) the failure of the Company to obtain the
assumption of this Agreement by any successors contemplated in Section 12. 
 
10.    Confidential Information.    Executive agrees to enter into the Company’s standard Confidential Information and Invention Assignment Agreement (the “Confidential
Information Agreement”) upon commencing employment hereunder. 
 
11.    Conditional Nature of Severance Payments. 
 
(a)    Noncompete.    Executive acknowledges that the nature of the Company’s business is such that if Executive were to become employed by, or
substantially involved in, the business of a competitor of the Company following the termination of Executive’s employment with the Company, it would be very difficult for Executive not to rely on or use the Company’s trade secrets and
confidential information. Thus, to avoid the inevitable disclosure of the Company’s trade secrets and confidential information, Executive agrees and acknowledges that Executive’s right to receive the severance payments set forth in Section
7 (to the extent Executive is otherwise entitled to such payments) 

 

3 

shall be conditioned upon Executive not directly or indirectly engaging in (whether as an employee, consultant, agent, proprietor, principal,
partner, stockholder, corporate officer, director or otherwise), nor having any ownership interest in or participating in the financing, operation, management or control of, any person, firm, corporation or business that competes with Company or is
a customer of the Company. Upon any breach of this section, all severance payments pursuant to this Agreement shall immediately cease. 
 
(b)    Non-Solicitation.    Until the date eighteen (18) months after the termination of
Executive’s employment with the Company for any reason, Executive agrees not, either directly or indirectly, to solicit, induce, attempt to hire, recruit, encourage, take away, hire any employee of the Company or cause an employee to leave his
or her employment either for Executive or for any other entity or person. Additionally, Executive acknowledges that Executive’s right to receive the severance payments set forth in Section 7 (to the extent Executive is otherwise entitled to
such payments) are contingent upon Executive complying with this Section 10(b) and upon any breach of this section all severance payments pursuant to this Agreement shall immediately cease. 
 
(c)    Understanding of
Covenants.    Executive represents that Executive (i) is familiar with the foregoing covenants not to compete and not to solicit, and (ii) is fully aware of Executive’s obligations hereunder, including, without
limitation, the reasonableness of the length of time, scope and geographic coverage of these covenants. 
 
12.    Assignment.    This Agreement will be binding upon and inure to the benefit of (a) the heirs, executors and legal representatives of Executive upon
Executive’s death and (b) any successor of the Company. Any such successor of the Company will be deemed substituted for the Company under the terms of this Agreement for all purposes. For this purpose, “successor” means any person,
firm, corporation or other business entity which at any time, whether by purchase, merger or otherwise, directly or indirectly acquires all or substantially all of the assets or business of the Company. None of the rights of Executive to receive any
form of compensation payable pursuant to this Agreement may be assigned or transferred except by will or the laws of descent and distribution. Any other attempted assignment, transfer, conveyance or other disposition of Executive’s right to
compensation or other benefits will be null and void. 
 
13.    Notices.    All notices, requests, demands and other communications called for hereunder shall be in writing and shall be deemed given (i) on the date of delivery if delivered
personally, (ii) one (1) day after being sent by a well established commercial overnight service, or (iii) four (4) days after being mailed by registered or certified mail, return receipt requested, prepaid and addressed to the parties or their
successors at the following addresses, or at such other addresses as the parties may later designate in writing: 
 
If to the Company: 
 
Natus Medical, Inc. 
1501 Industrial Road 
San Carlos, CA 94070 
Attn: Mark Foster, General Counsel 
 
If to Executive: 
at the last residential address known by the Company. 
 
14.    Severability.    In the event that any provision hereof becomes or is
declared by a court of competent jurisdiction to be illegal, unenforceable or void, this Agreement will continue in full force and effect without said provision. 
 

	15.    Arbitration.	 	

 
(a)    General.    In consideration of Executive’s service to the Company, its promise
to arbitrate all employment related disputes and Executive’s receipt of the compensation, pay raises and other benefits paid to Executive by the Company, at present and in the future, Executive agrees that any and all controversies, claims, or
disputes with anyone (including the Company and any employee, officer, director, shareholder or benefit plan of the Company in their capacity as such or otherwise) arising out of, relating to, or resulting from Executive’s service to the
Company under this Agreement or otherwise or the termination of Executive’s service with the Company, including any breach of this Agreement, shall be subject to binding arbitration under the Arbitration Rules set forth in California Code of
Civil Procedure Section 1280 through 1294.2, including Section 1283.05 (the “Rules”) and pursuant to California law. 

 

4 

Disputes which Executive agrees to arbitrate, and thereby agrees to waive any right to a trial by jury, include any statutory claims under
state or federal law, including, but not limited to, claims under Title VII of the Civil Rights Act of 1964, the Americans with Disabilities Act of 1990, the Age Discrimination in Employment Act of 1967, the Older Workers Benefit Protection Act, the
California Fair Employment and Housing Act, the California Labor Code, claims of harassment, discrimination or wrongful termination and any statutory claims. Executive further understands that this Agreement to arbitrate also applies to any disputes
that the Company may have with Executive. 
 
(b)    Procedure.    Executive agrees that any arbitration will be administered by the American Arbitration Association (“AAA”) and that a neutral arbitrator will be selected
in a manner consistent with its National Rules for the Resolution of Employment Disputes. The arbitration proceedings will allow for discovery according to the rules set forth in the National Rules for the Resolution of Employment Disputes or
California Code of Civil Procedure. Executive agrees that the arbitrator shall have the power to decide any motions brought by any party to the arbitration, including motions for summary judgment and/or adjudication and motions to dismiss and
demurrers, prior to any arbitration hearing. Executive agrees that the arbitrator shall issue a written decision on the merits. Executive also agrees that the arbitrator shall have the power to award any remedies, including attorneys’ fees and
costs, available under applicable law. Executive understands the Company will pay for any administrative or hearing fees charged by the arbitrator or AAA except that Executive shall pay the first $200.00 of any filing fees associated with any
arbitration Executive initiates. Executive agrees that the arbitrator shall administer and conduct any arbitration in a manner consistent with the Rules and that to the extent that the AAA’s National Rules for the Resolution of Employment
Disputes conflict with the Rules, the Rules shall take precedence. 
 
(c)    Remedy.    Except as provided by the Rules, arbitration shall be the sole, exclusive and final remedy for any dispute between Executive and the Company. Accordingly,
except as provided for by the Rules, neither Executive nor the Company will be permitted to pursue court action regarding claims that are subject to arbitration. Notwithstanding, the arbitrator will not have the authority to disregard or refuse to
enforce any lawful Company policy, and the arbitrator shall not order or require the Company to adopt a policy not otherwise required by law that the Company has not adopted. 
 
(d)    Availability of Injunctive Relief.    In addition to
the right under the Rules to petition the court for provisional relief, Executive agrees that any party may also petition the court for injunctive relief where either party alleges or claims a violation of this Agreement or the Confidentiality
Agreement or any other agreement regarding trade secrets, confidential information, nonsolicitation or Labor Code §2870. In the event either party seeks injunctive relief, the prevailing party shall be entitled to recover reasonable costs and
attorneys’ fees. 
 
(e)    Administrative Relief.    Executive understands that this Agreement does not prohibit Executive from pursuing an administrative claim with a local, state or federal administrative
body such as the Department of Fair Employment and Housing, the Equal Employment Opportunity Commission or the workers’ compensation board. This Agreement does, however, preclude Executive from pursuing court action regarding any such claim.

 
(f)    Voluntary Nature
of Agreement.    Executive acknowledges and agrees that Executive is executing this Agreement voluntarily and without any duress or undue influence by the Company or anyone else. Executive further acknowledges and agrees that
Executive has carefully read this Agreement and that Executive has asked any questions needed for Executive to understand the terms, consequences and binding effect of this Agreement and fully understand it, including that Executive is waiving
Executive’s right to a jury trial. Finally, Executive agrees that Executive has been provided an opportunity to seek the advice of an attorney of Executive’s choice before signing this Agreement. 
 
16.    Integration.    This
Agreement, together with the Option Plan, Option Agreement and the Confidential Information Agreement represents the entire agreement and understanding between the parties as to the subject matter herein and supersedes all prior or contemporaneous
agreements whether written or oral. No waiver, alteration, or modification of any of the provisions of this Agreement will be binding unless it is in writing and specifically mentions this Section 16 and it is signed by duly authorized
representatives of the parties hereto. 
 
17.    Waiver of Breach.    The waiver of a breach of any term or provision of this Agreement, which must be in writing, shall not operate as or be construed to be a waiver of any other
previous or subsequent breach of this Agreement. 
 

5 

 
18.    Headings.    All captions and section headings used in this Agreement are for convenient reference only and do not form a part of this Agreement. 
 
19.    Tax Withholding.    All
payments made pursuant to this Agreement will be subject to withholding of applicable taxes. 
 
20.    Governing Law.    This Agreement will be governed by the laws of the State of California (with the exception of its conflict of laws provisions).

 
21.    Acknowledgment.    Executive acknowledges that he has had the opportunity to discuss this matter with and obtain advice from his private attorney, has had sufficient time to, and
has carefully read and fully understands all the provisions of this Agreement, and is knowingly and voluntarily entering into this Agreement. 
 
22.    Counterparts.    This Agreement may be executed in counterparts, and each counterpart shall have the
same force and effect as an original and shall constitute an effective, binding agreement on the part of each of the undersigned. 
 
 
[Remainder of Page Intentionally Left Blank]

 
 

6 

 
IN WITNESS WHEREOF, each of
the parties has executed this Agreement, in the case of the Company by their duly authorized officers, as of the day and year first above written. 
 

	 COMPANY:
 NATUS MEDICAL, INC.
	 	 
	
	 By:
	 	 /s/    GLENN A. BAUER

	 	 Date:
	 	     11/19/02

	 	 	 Glenn A. Bauer
	 	 	 	 
	
	 Title:
	 	 Chief Financial Officer
	 	 	 	 

 
 

	 EXECUTIVE:
	 	 
	
	  
 /s/    TIM C.
JOHNSON                                   
 

	 	 Date:
	 	     11/19/02

	 Tim C. Johnson
	 	 	 	 

 
 
 
SIGNATURE PAGE TO TIM C. JOHNSON’S EMPLOYMENT AGREEMENT

 

7

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00049-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00049-of-00352.parquet"}]]